Clinical Trial

A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis

Name: A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis — clinical trial record (NCT07436234)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe SAR

Trial Details

NCT Number	NCT07436234
Lead Sponsor	Akeso
Conditions	Seasonal Allergic Rhinitis
Enrollment	111 participants
Start Date	2026-03-02
Primary Completion	2026-09-30 (estimated)
Study Completion	2027-05-13 (estimated)
Updated on ClinicalTrials.gov	2026-02-27